‘Basic Bronze’ proposal to cut health insurance premiums

1 May 2017 - Health funds would be compelled to offer a standard, low-cost ­insurance policy under a proposal being ...

Read more →

The multi-billion-dollar subsidy for private health insurance isn’t worth it

27 April 2017 - Almost 20 years after the 30% subsidy for private health insurance was introduced, premiums continue to ...

Read more →

Brenzys lists on the Australian PBS and Pfizer denied discovery of documents to establish grounds for patent infringement

4 April 2017 - As of 1 April 2017, Samsung Bioepis' Brenzys, a biosimilar to Pfizer's Enbrel (etanercept), will join ...

Read more →

$30m damages for infringement of Bayer’s Australian Yasmin patent - a “small” jurisdiction with big benefits

29 March 2017 - In a recent landmark Australian Federal Court decision, Bayer v Generic Health FCA 250, Bayer was awarded ...

Read more →

National Health Amendment (Pharmaceutical Benefits) Act 2017

29 March 2017 - The National Health Amendment (Pharmaceutical Benefits) Bill 2016 was passed in the House of Representatives on ...

Read more →

Federal Court of Australia dismisses preliminary discovery application regarding biosimilar suspected of infringing manufacturing process patents

26 March 2017 - In the recent decision of Pfizer Ireland Pharmaceuticals v Samsung Bioepis, Justice Stephen Burley of the Federal ...

Read more →

Medibank skips health insurance grilling

15 March 2017 - Medibank won't join other health funds to explain soaring private health insurance premiums at a parliamentary ...

Read more →

Medibank Private 'highhanded', 'cynical' in misleading consumers: ACCC

14 March 2017 - Australia's largest health insurer Medibank has been accused of "cynical" and "high-handed" conduct that misled and ...

Read more →

Battle over hips and the hip pocket as prostheses costs fight heats up

12 March 2017 - Australia's medical technology bodies are gearing up for battle as the cost of replacement hips, knees ...

Read more →

Industry group versus California newcomer in medical technology price row

9 March 2017 - The industry lobby group representing medical device manufacturers has rejected claims by a US manufacturer that ...

Read more →

The secret slug that will make the $200 annual increase in health fund premiums cost more

10 March 2017 - It's the secret double whammy that means next month’s health fund premium rise will hit your ...

Read more →

Moves to end veto on health insurance premiums

9 March 2017 - Health insurers are stepping up their campaign to end government veto power over insurance premiums, arguing ...

Read more →

Drug pricing report shows scope for more savings

6 March 2017 - The savings to the taxpayer in reducing the cost to Government of prescribed pharmaceuticals has been ...

Read more →

Response to the Grattan Institute Report on medicine prices

6 March 2017 - Medicines Australia does not accept the findings of this latest inaccurate, selective and misleading Grattan Report ...

Read more →

Indicative 1 April 2017 prices - 2017 April cycle

23 January 2017 - Indicative 1 April 2017 prices resulting from the 2017 April cycle of price disclosure have now been ...

Read more →